X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New report celebrates a decade of progress in chronic diseases

By Holly Campbell  |    February 25, 2016
In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...   Read More

Burden on Patients: 5 Questions on access to multiple sclerosis medicines in health exchange plans

By Allyson Funk  |    December 4, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to...   Read More

New PhRMA and Epilepsy Foundation Report: 420 Medicines in Development for Neurological Disorders

By Tina Stow  |    July 13, 2015
It’s hard to imagine, but there are currently more than 50 million Americans – nearly one-sixth of our population – affected by some type of neurological disorder. While some of these are more...   Read More

New Evidence of Discrimination in Essential Health Benefit Plans

By Tina Stow  |    January 30, 2015
While the Affordable Care Act (ACA) expanded access to health insurance coverage for millions, a new study from the Harvard T.H. Chan School of Public Health reveals that insurers may be...   Read More

Burden on Patients: One-Size-Fits-All Approach to Treating Multiple Sclerosis Hurts Patients

By Allyson Funk  |    July 2, 2014
Recently, we discussed the obstacles patients face in managing chronic conditions such as mental health disorders, HIV/AIDS and Rheumatoid Arthritis under the Affordable Care Act’s health...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates